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Calcium signaling is a universal signal transduction mechanism in animal and plant cells.
In mammalian T-lymphocytes calcium signaling is essential for activation and re-activation
and thus important for a functional immune response. Since many years it has been known
that both calcium release from intracellular stores and calcium entry via plasma membrane
calcium channels are involved in shaping spatio-temporal calcium signals. Second messen-
gers derived from the adenine dinucleotides NAD and NADP have been implicated inT cell
calcium signaling. Nicotinic acid adenine dinucleotide phosphate (NAADP) acts as a very
early second messenger upon T cell receptor/CD3 engagement, while cyclic ADP-ribose
(cADPR) is mainly involved in sustained partial depletion of the endoplasmic reticulum by
stimulating calcium release via ryanodine receptors. Finally, adenosine diphosphoribose
(ADPR) a breakdown product of both NAD and cADPR activates a plasma membrane
cation channel termed TRPM2 thereby facilitating calcium (and sodium) entry into T cells.
Receptor-mediated formation, metabolism, and mode of action of these novel second
messengers in T-lymphocytes will be reviewed.
Keywords: calcium signaling,T-lymphocyte, calcium release, nicotinic acid adenine dinucleotide phosphate, cyclic
ADP-ribose, adenosine diphosphoribose,TRPM2 cation channels, calcium entry
Adenine derived Ca2+ mobilizing second messengers comprise
nicotinic acid adenine dinucleotide phosphate (NAADP), cyclic
ADP-ribose (cADPR), and adenosine diphosphoribose (ADPR;
Figure 1). They are all metabolites of nicotinamide adenine din-
ucleotide (NAD), a dinucleotide well known as coenzyme of
oxidoreductases. NAD is converted by the multifunctional ectoen-
zyme NAD-glycohydrolase/ADP-ribosyl cyclase CD38 to ADPR
and cADPR (Figure 1). The fact that the active site of CD38 faces
the extracellular space while the targets for its products are located
inside the cell, also known as topological paradox (1), has recently
been investigated in detail. Importantly, in addition to the type II
conformation with the active site facing the extracellular space, it
was demonstrated that a smaller portion of CD38 is expressed in
type III conformation thereby allowing for production of ADPR
and cADPR within the cytosol (2). Another interesting feature of
CD38 is the fact that it not only can make cADPR and ADPR,
but also can synthesize NAADP, at least in vitro (Figure 1). How-
ever, this base-exchange mechanism needs nicotinamide adenine
dinucleotide phosphate (NADP) and an excess of nicotinic acid
as substrates and it works at acidic pH. Thus, it remains unclear
Abbreviations: ADPR, adenosine diphosphoribose; cADPR, cyclic ADP-ribose;
[Ca2+]i, free cytosolic Ca2+ concentration; [Ca2+]lu, free endoplasmic reticular
luminal Ca2+ concentration; CICR, Ca2+-induced Ca2+ release; EAE, experi-
mental autoimmune encephalomyelitis; IP3, d-myo inositol 1,4,5-trisphosphate;
IP3R, d-myo inositol 1,4,5-trisphosphate receptor(s); NAADP, nicotinic acid ade-
nine dinucleotide phosphate; NAD(P), nicotinamide adenine dinucleotide (phos-
phate); pADPr, poly-ADP-ribose; PARG, poly-ADP-ribose glycohydrolase; PARP,
poly-ADP-ribose polymerase; RyR, ryanodine receptor(s); Stim1, stromal interac-
tion molecule-1; TPC, two-pore channel(s); TRPM2, transient receptor potential
channel, subtype melastatin 2.
whether this reaction is of physiological significance for second
messenger formation in the cytosol. The substrate for the base-
exchange reaction, NADP, is produced from NAD by NAD kinase
(3). While mature, naïve T cells express only small amounts of
CD38, it is upregulated as a consequence of mitogenic stimula-
tion (4, 5). This is for instance seen after infection with HIV in
activated antiviral CD8+ T cells (6). CD38 expression in the CD8
compartment is therefore used to monitor antiretroviral therapy
(7). Whether CD38 upregulation in activated T cells affects Ca2+
signaling compared to naïve, mature T cells is not known, but it is
easy to envision the production of Ca2+ mobilizing messengers in
effector cells being facilitated by upregulation of CD38, allowing
for faster Ca2+ responses necessary for secretion of cytokines or
granzymes and perforin in contrast to activation of calcineurin
and NFAT in naïve cells.
Ca2+ signaling is one of the essential intracellular signal-
ing pathways involved in T cell activation. It has long been
known that both Ca2+ release and Ca2+ entry contribute to
global Ca2+ signaling in T cells. In addition to Ca2+ release and
Ca2+ entry evoked by the adenine derived Ca2+ mobilizing sec-
ond messengers introduced above, two “standard” Ca2+ signaling
systems are involved: (i) Ca2+ release by d-myo-inositol 1,4,5-
trisphosphate [IP3; (8)] and store-operated or capacitative Ca2+
entry (9). Since these systems have been thoroughly investigated
and described in detail, they will not be reviewed in this arti-
cle. However, due to their importance for T cell Ca2+ signaling,
their roles will be mentioned and/or depicted, as for example in
Figure 2.
The initial player in our model of T cell Ca2+ signaling is
NAADP (Figure 2) being formed within seconds upon TCR/CD3
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FIGURE 1 | Metabolism of adenine derived second messengers cADPR, NAADP, and ADPR.
ligation (10). However, NAADP is a rather short-lived second
messenger, although after a rapid decrease to control levels, a
second much smaller rise over several minutes was observed in
Jurkat T cells (11). NAADP probably delivers the first local Ca2+
signals which then act as co-agonists at IP3 receptors (IP3R) and
ryanodine receptors (RyR). IP3 is formed soon after the initial
NAADP peak (12) and releases Ca2+ via IP3R (13). Finally, cADPR
starts to increase and acts on RyR (14); likely, Ca2+ released by
NAADP and/or IP3 facilitates the action of cADPR. Continuous
Ca2+ release by these consecutively increased second messengers
results in continuously decreased luminal Ca2+ concentration in
the ER ([Ca2+]lu). Stromal interaction molecule-1 (Stim1) senses
the decreased [Ca2+]lu and activates Ca2+ entry via orai/CRAC
channels (15–17).
In addition to this Ca2+ signaling pathway involved in T
cell activation or re-activation, high input signal strength, e.g.,
obtained by a high concentration of the cross-linking lectin
Concanavalin A, activates another different Ca2+ entry system
operated by ADPR and the transient receptor potential channel,
subtype melastatin 2 (TRPM2; Figure 2).
Following we will review hallmarks of NAADP, cADPR, and
ADPR as second messengers in T cell Ca2+ signaling.
NAADP
Upon activation of the TCR/CD3 complex, formation of NAADP
rapidly increases within 10–20 s in Jurkat T cells. Following a
subsequent decrease within the first minute, a continuously ele-
vated [NAADP] remains for 5–20 min (10). It has been proposed
that NAADP may act as an early triggering messenger, mediating
initial localized Ca2+ events which are subsequently amplified to a
global signal, e.g., by recruitment of further channels, other second
messengers like cADPR, IP3, and/or Ca2+ induced Ca2+ release
(CICR). In T-lymphocytes a bell-shaped concentration-response
curve following NAADP microinjection is observed. Compared to
other second messengers such as IP3, already low concentrations
in the nanomolar range (30–100 nM) induce Ca2+ signaling in
T-lymphocytes (18).
The mechanism and very early kinetics of receptor-mediated
formation of NAADP in vivo remains unclear and has been dis-
cussed previously [e.g., (19)]. In brief, NAADP is formed in vitro
by a base-exchange of NADP in presence of nicotinic acid and
a pH of 5 [Figure 1; (20)]. Further, at pH 5, but also at pH
7.4, 2′-phospho-cADPR may be converted to NAADP (21). Both
reactions are catalyzed by the membrane bound, multifunctional
enzyme CD38 and require presence of up to millimolar concen-
trations of nicotinic acid in vitro (20, 21). Furthermore, influx of
extracellular NAADP may also induce Ca2+ signals as shown in a
rat basophilic cell line (22). Interestingly, gene silencing of CD38
in Jurkat T-lymphocytes did not result in decreased NAADP levels.
Rather, in thymus and spleen of CD38 knock-out mice increased
NAADP levels were observed, thus indicating that CD38 may par-
ticularly drive degradation of NAADP (23, 24). Accordingly, in
T cells to date CD38 may be primarily understood as degrading
enzyme while its role in NAADP synthesis in vivo remains to be
elucidated. In T-lymphocytes and other CD38+ cells, NAADP is
degraded to 2′-phospho-ADPR at neutral and acidic pH by CD38,
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FIGURE 2 | Model ofT cell Ca2+ signaling. TCR/CD3 ligation by antigenic
peptide presented by MHC molecules on antigen presenting cells results in
consecutive formation of the second messengers NAADP, IP3, and cADPR, all
of which release Ca2+ from the ER. Thus, a continuously decreased
intraluminal free Ca2+ concentration in the ER ([Ca2+]lu) resulting from this
constant Ca2+ release concomitantly activates CRAC/Orai1 channels in the
plasma membrane. The mode of action of both NAADP and cADPR likely
involves specific binding proteins for both second messengers (abbreviated
here as NAADP-BP or cADPR-BP). A strong stimulus, e.g., cross-linking of
receptors by concanavalin A (right side of Figure 2), triggers formation of
ADPR and activation of TRPM2, in addition to the mechanisms described on
the left side of the figure.
but degradation may also occur non-specifically via nucleotide
pyrophosphatases (25).
The targeted receptor(s) and hence target organelle(s) of
NAADP are still under debate (19, 26–29). In general, RyR have
been implicated as NAADP targets in different cell types, e.g., skele-
tal muscle cell (30), or pancreatic acinar cells (31, 32). Nonetheless,
in the majority of mammalian cells as well as in sea urchin eggs
there is evidence that NAADP may primarily target acidic stores
and that the RyR located on the ER may rather play a central role
in the amplification of the Ca2+ signal (33–35).
However focusing particularly on data obtained in T-
lymphocytes, NAADP Ca2+ signaling strongly depends on RyR
activity in the ER (36–40). Following either knock-down or inhi-
bition of RyR by ryanodine in Jurkat T cells, subcellular and
global Ca2+ signals by NAADP microinjection were inhibited
or almost completely abolished (36, 38). In primary effector T-
lymphocytes the NAADP antagonist BZ194 inhibits Ca2+ signal-
ing, e.g., during formation of the immunological synapse. Fur-
thermore, BZ194 has been shown to selectively inhibit NAADP
dependent binding of [3H]ryanodine to RyR1 (39). Interestingly,
in primary effector T cells of an animal model of multiple sclerosis,
experimental autoimmune encephalomyelitis (EAE), BZ194 leads
to a decrease in cell motility and invasive capacity as well as a
decrease in cytokine expression, all of which indicate the cen-
tral role of NAADP-mediated Ca2+ signaling in T cells possibly
via RyR (40). In contrast to these results obtained in CD4+ T
cells, in cytotoxic T cells NAADP appears to target two-pore
channels (TPC) on cytolytic granules (41). In general, overex-
pression or inhibition of the endolysosomal TPC1 and TPC2
suggest that NAADP initiates Ca2+ events via TPC [e.g., (42–
44)]. Recently, the N-terminus of TPC1 has been identified as
functional region for NAADP-mediated Ca2+ signaling (26). In
contrast, it was shown that NAADP-mediated Ca2+ signaling in
TPC1−/−/TPC2−/−mice does not differ from wild-type mice (27).
Thus, whether NAADP primarily targets TPCs is controversial and
particularly the effect of NAADP on TPCs in T-lymphocytes is not
yet clear.
Further, in T-lymphocytes and neutrophils TRPM2 is activated
by micromolar concentrations of NAADP per se, but particu-
larly in synergism with cADPR (45, 46). The effect of cADPR
on TRPM2 however, could not be confirmed in HEK293 cells
overexpressing TRPM2 and contamination of commercial cADPR

























































Ernst et al. Adenine dinucleotide messengers in T-lymphocytes
preparations with ADPR have been discussed (47, 48). NAADP
has been shown to target the unspecific Ca2+ channel TRPML1 in
smooth muscle myocytes (49). Whether TRPML1 and TRPM2 are
of functional relevance within NAADP – mediated Ca2+ signaling
in T-lymphocytes, remains to be elucidated.
Despite the questions which organelles are targeted by NAADP
and which specific downstream mechanisms may underlie the
initiated Ca2+ events, also the identity of the NAADP receptor
remains unclear. Photoaffinity labeling in mammalian cells using
a probe specific for NAADP binding proteins was not altered upon
overexpression or knock-out of TPC1 or TPC2, but suggests that
a yet not identified 22/23 kDa protein binds NAADP and may
hence couple NAADP to its respective Ca2+ channels (50, 51), a
mechanism recently introduced as unifying hypothesis of NAADP
action (29).
CYCLIC ADP-RIBOSE
Cyclic adenosine diphosphoribose (cADPR) was the first Ca2+
mobilizing second messenger discovered as derivative of an ade-
nine dinucleotide (52, 53). Though first described in sea urchin
egg homogenates, the Ca2+ mobilizing activity of cADPR was
soon detected in many cells types. In 1995 we published the first
report demonstrating specific Ca2+ release in human Jurkat T
cells (54). Central aspects of the role of cADPR in T cell Ca2+
signaling were subsequently published by our laboratory: (i) for-
mation of cADPR upon TCR/CD3 ligation (14, 55), and (ii) mode
of action of cADPR by activation of Ca2+ release via RyR, as
shown by gene silencing of RyR (56). Further, we demonstrated
tyrosine phosphorylation of RyR upon TCR/CD3 ligation; in per-
meabilized T cells enhancement of cADPR evoked Ca2+ release by
tyrosine kinase p59fyn was observed (57). Importantly, we demon-
strated amplification and propagation of pacemaker Ca2+ signals
by cADPR (58). A connection of cADPR signaling to Ca2+ entry
was also observed: microinjection of cADPR in the absence of
extracellular Ca2+ or in the presence of Ca2+ channel blockers
resulted in much reduced Ca2+ signals (59). Finally, using a spe-
cific cADPR antagonist it was shown that downstream activation
parameters of primary human T cells, such as activation anti-
gen expression or proliferation, were concentration-dependently
inhibited (14) suggesting a pivotal role of cADPR in T cell biology.
A detailed structure-activity analysis of cADPR in T cells has
been conducted over the past couple of years. The main results
from these studies were recently reviewed (60) and are (i) critical
dependence of agonist vs. antagonist properties on the substituent
at the C-atom 6 of the purine base, (ii) maintenance of biological
activity, albeit at a lower level, when both southern and north-
ern ribose were replaced by carbocyclic moieties or simplified
ether/alkane bridges, and (iii) the possibility of radical simpli-
fication of the purine structure, e.g., the 1,2,3-triazole-4-amide
mimic of adenine within cADPR retains biological activity.
ADPR
A relatively new addition to the realm of adenine based Ca2+
mobilizing second messengers in T-lymphocytes is ADPR. Pres-
ence of ADPR in eukaryotic cells has been known for quite a while
(61), but since ADPR is rather dangerous for the cell – its reac-
tive ribose can non-enzymatically form Schiff-bases with amino
groups of cellular proteins (62, 63) – it was mostly considered a
toxic cellular waste product. This casually explained the presence
of efficient mechanisms for the degradation of ADPR in form
of cytosolic (64, 65) and mitochondrial ADPR pyrophosphatases
(66, 67). These enzymes hydrolyze the pyrophosphate bridge of
ADPR yielding AMP and ribose-5′-phosphate that are fed back
into metabolism.
Two discoveries suggested that there might be more to ADPR:
in 2001 it was reported that TRPM2 (formerly termed TRPC7 or
LTRPC2), a Ca2+-permeable cation channel of the melastatin sub-
family of TRP channels, can be activated by binding of ADPR to
a cytoplasmic domain homologous to the mitochondrial ADPR
pyrophosphatase NUDT9 (68, 69). This channel shows expression
in a variety of tissues with highest levels being found in brain and
cells of the immune system. A year later Bastide et al. showed that
ADPR is also able to activate type I RyR isolated from rat skele-
tal muscle in the presence of micromolar concentrations of Ca2+
(70). Since there has been little news on the action of ADPR on
RyR, we will focus on the role of ADPR for TRPM2 activation in
T-lymphocytes.
Most of the work on ADPR and TRPM2 in T cells so far
has been done in Jurkat cells that express TRPM2 on transcript
and protein level and respond with a typical TRPM2 current to
ADPR infusion (11, 45, 69). Microinjection of ADPR (11) and
uncaging of photoactivatable ADPR (71) in these cells results in
Ca2+ entry-dependent Ca2+ signals. By HPLC analysis the cellu-
lar ADPR concentration of roughly 40µmol/L in resting Jurkat
cells (72) was shown to nearly double after stimulation with high
concentrations of concanavalin A (11).
There are different conceivable ways how this ADPR might be
generated. CD38 expressed in Jurkat as well as primary T cells
(73) can metabolize β-NAD+ and cADPR to yield ADPR (74).
The topological paradox initially described for cADPR also holds
true for ADPR (1). This paradox might be resolved by specific
uptake mechanisms for ADPR as have been reported for ery-
throcytes (75, 76). Another possibility is the presence of CD38
in a type III orientation (2). While the contribution of CD38
to the increase in ADPR after stimulation is still unclear, the
basal ADPR seems to be independent of CD38 as the murine
T-lymphoma line BW5147 that lacks transcripts for CD38 (77)
has even higher basal ADPR levels [73µmol/L (72)] than Jurkat
cells.
Another way that has been discussed for the production of
ADPR is the consecutive action of poly-ADPR polymerase (PARP)
and poly-ADPR glycohydrolase (PARG) (78). While PARP activity
and poly-ADPR levels are quite low in non-stimulated cells, there
is a constant turn-over due to the low KM of PARG [reviewed in
(79)] that might contribute to the basal ADPR detected in Jurkat
cells. Under DNA damaging conditions like strong oxidative stress
the activity of PARP increases to such levels that a large part of cel-
lular β-NAD+ can be metabolized as has been shown for DT-40
cells (80). Data for a range of cells suggest activation of TRPM2
by oxidative stress results in cell death by apoptosis (78, 81), most
likely due to mitochondrial calcium overload and downstream
activation of caspases [reviewed in (82)]. While murine CD4+ T
cells also die after exposure to hydrogen peroxide, this apparently
does not involve TRPM2 (83).
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Interestingly there have been reports that in T cells PARP-1
activation can occur after TCR stimulation in a way indepen-
dent of oxidative stress or DNA damage resulting in poly-ADP
ribosylation of NFAT [(84, 85); reviewed in (86)]. It might be
speculated that this increased pADPR turn-over will result in
increased cellular ADPR and TRPM2 activation hinting to a pos-
sible role for ADPR/TRPM2 in TCR signaling. In accordance with
this, naïve CD4+ T cells from the wild-type mice upregulated
TRPM2 after stimulation with α-CD3/α-CD28-beads and CD4+
T-lymphocytes from TRPM2−/− mice showed not only reduced
proliferation, but also reduced production of pro-inflammatory
cytokines upon activation (83).
Most work on the role of TRPM2 in the immune response
has been done using the TRPM2−/− mouse (87). In a model
for ulcerative colitis the inflammation was suppressed, but this
was shown to be due to a reduced production of the chemokine
CXCL2 in monocytes whereas the infiltration of T cells in the
colon was not affected by the knock-out of TRPM2 (87). Recent
work has shown that TRPM2 knock-out does not affect airway
inflammation either induced by oxidative stressors (88) or as
a result of exposure to ovalbumin in a mouse model for acute
asthma (89). On the other hand TRPM2−/− noticeably reduced
inflammation and spinal cord lesions in EAE induced by a peptide
from myelin oligodendrocyte glycoprotein (83). Since the effect
of TRPM2−/− on EAE might also involve reduced neuronal cell
death or microglia activation, it will be interesting to see whether
proliferation and effector functions of T cells from such animals
are affected.
Taken together, adenine derived Ca2+ mobilizing second mes-
sengers play essential roles in T cell Ca2+ signaling, both during
activation/re-activation or apoptosis. While NAADP is impor-
tant as rapid Ca2+ trigger, particularly in effector T cells, cADPR
apparently holds a central role in maintenance of long-lasting
Ca2+ signaling. Interestingly, also apoptosis induction via TRPM2
involves an adenine derived second messenger, the dinucleotide
ADPR. The documented involvement of these adenine derived
Ca2+ mobilizing second messengers in central aspects of immune
regulation make the pathways described in this review suitable tar-
gets for therapeutic intervention. In fact, we have recently shown
that the NAADP antagonist BZ194 ameliorated the clinical course
of transfer EAE, an animal model of multiple sclerosis (40).
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